These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11520910)

  • 1. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
    Rideout HJ; Larsen KE; Sulzer D; Stefanis L
    J Neurochem; 2001 Aug; 78(4):899-908. PubMed ID: 11520910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination.
    Rideout HJ; Stefanis L
    Mol Cell Neurosci; 2002 Oct; 21(2):223-38. PubMed ID: 12401444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
    Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
    J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions.
    Sawada H; Kohno R; Kihara T; Izumi Y; Sakka N; Ibi M; Nakanishi M; Nakamizo T; Yamakawa K; Shibasaki H; Yamamoto N; Akaike A; Inden M; Kitamura Y; Taniguchi T; Shimohama S
    J Biol Chem; 2004 Mar; 279(11):10710-9. PubMed ID: 14672949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.
    Rideout HJ; Dietrich P; Wang Q; Dauer WT; Stefanis L
    J Biol Chem; 2004 Nov; 279(45):46915-20. PubMed ID: 15322100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
    Tofaris GK; Layfield R; Spillantini MG
    FEBS Lett; 2001 Nov; 509(1):22-6. PubMed ID: 11734199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
    Tanaka Y; Engelender S; Igarashi S; Rao RK; Wanner T; Tanzi RE; Sawa A; L Dawson V; Dawson TM; Ross CA
    Hum Mol Genet; 2001 Apr; 10(9):919-26. PubMed ID: 11309365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective.
    Tanaka M; Kim YM; Lee G; Junn E; Iwatsubo T; Mouradian MM
    J Biol Chem; 2004 Feb; 279(6):4625-31. PubMed ID: 14627698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.
    Stefanis L; Larsen KE; Rideout HJ; Sulzer D; Greene LA
    J Neurosci; 2001 Dec; 21(24):9549-60. PubMed ID: 11739566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
    Waelter S; Boeddrich A; Lurz R; Scherzinger E; Lueder G; Lehrach H; Wanker EE
    Mol Biol Cell; 2001 May; 12(5):1393-407. PubMed ID: 11359930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
    Rideout HJ; Wang Q; Park DS; Stefanis L
    J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
    Elkon H; Melamed E; Offen D
    Cell Mol Neurobiol; 2001 Dec; 21(6):771-81. PubMed ID: 12043847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
    McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
    J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition.
    Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Busceti CL; Ruffoli R; Soldani P; Ruggieri S; Alessandri MG; Paparelli A
    J Neurosci; 2003 Oct; 23(26):8955-66. PubMed ID: 14523098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition.
    Rideout HJ; Lang-Rollin IC; Savalle M; Stefanis L
    J Neurochem; 2005 Jun; 93(5):1304-13. PubMed ID: 15934949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
    J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
    Ancolio K; Alves da Costa C; Uéda K; Checler F
    Neurosci Lett; 2000 May; 285(2):79-82. PubMed ID: 10793231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasomal function is impaired in substantia nigra in Parkinson's disease.
    McNaught KS; Jenner P
    Neurosci Lett; 2001 Jan; 297(3):191-4. PubMed ID: 11137760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.